Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NTM-net Study: Liposomal Amikacin Inhalation in M.Abscessus Patients

NCT04163601 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04163601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04163601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NTM-net Study: Liposomal Amikacin Inhalation in M.Abscessus Patients
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2019
Completion date
March 31, 2024
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

m.abscessus pulmonary disease